Ottaviani, G., & Jaffe, N. (2009). The epidemiology of osteosarcoma. Cancer Treatment and Research, 152, 3-13. https://doi.org/10.1007/978-1-4419-0284-9_1
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer, 115(7), 1531-1543. https://doi.org/10.1002/cncr.24121
Whelan, J. S., Davis, L. E., & Bielack, S. (2022). Current and future approaches to osteosarcoma treatment: Advances in molecular and immune therapies. The Lancet Oncology, 23(11), e556-e567. https://doi.org/10.1016/S1470-2045(22)00522-3
Davis, L. E., Bolejack, V., Ryan, C. W., et al. (2021). Randomized phase II study of pembrolizumab in patients with advanced osteosarcoma. Journal of Clinical Oncology, 39(27), 3109-3117. https://doi.org/10.1200/JCO.21.00007
